STIM

#4006
Neuronetics, Inc. Common Stock
1.43 USD
+2.88%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
1.43
1.43
年范围
0.80
4.82
日变化
+2.88%
每月变动
+5.93%
6个月变化
-51.69%
年变化
-62.37%
前一天收盘价
1.39
开盘价
1.43
买价
卖价
最低价
1.43
High
1.43
交易量
29
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 99.07 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-2.34
市销率
0.65

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

新闻